OR WAIT null SECS
© 2021 MJH Life Sciences and Cancer Network. All rights reserved.
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Shared insight on strategies for optimizing frontline therapy for patients with newly diagnosed multiple myeloma, including those with high-risk disease.
October 22nd 2021
After reviewing the case of a patient with transplant-eligible newly-diagnosed multiple myeloma, experts consider optimal selection of first-line treatment.
October 29th 2021
Shared insight on the evolving treatment landscape of transplant-ineligible newly diagnosed multiple myeloma.
November 5th 2021
Concluding their discussion on newly diagnosed multiple myeloma, expert panelists consider treatment options for patients with high-risk disease.